VoiceMed raises €528K Seed round
17 February 2026· Rome, Italy· health, diagnostics, ai, b2b, pure_software
The funding will be used to accelerate clinical studies for VoiceMed's home monitoring solutions for Chronic Obstructive Pulmonary Disease (COPD), validate their use in real-world settings, and support initial market entry activities.
Investors
LeadInvitalia
Also participating
28DIGITALGCM GroupPadda Health
About VoiceMed
Stage
Seed
Headquarters
Rome, Italy
Founded
2020
Team Size
6–20
Sectors
healthdiagnosticsaib2bpure_software